Table 2 Prevalence of antibiotics resistance among MRSA and MSSA strains from the two groups of lesions
MRSA | MSSA | |||||||
|---|---|---|---|---|---|---|---|---|
|  | Infectious Group N = 16 | Non-infectious Group N = 43 | χ2, P-Value | Total N = 59 | Infectious Group N = 14 | Non-infectious Group N = 32 | χ2, P- Value | Total N = 46 |
L | 3(18.7%) | 8(32%) | .990 | 11(18.6%) | 2(14.2%) | 4(12.5%) | .869 | 6(13.3%) |
Mu | 1(6.2%) | 12(27.9%) | .074 | 13(22%) | 3(21.4%) | 6(18.7%) | .833 | 9(19.5%) |
C | 0 | 2(4.6%) | .278 | 2(3.3%) | 0 | 0 | – | 0 |
AK | 2(12.5%) | 8(18.6%) | .578 | 10(16.9%) | 0 | 1(3.1%) | .504 | 1(2.1%) |
T | 8(50%) | 13(30.2%) | .159 | 21(35.5%) | 5(35.7%) | 8(25%) | .458 | 13(28.2%) |
PG | 16(100%) | 39(90.6%) | .206 | 55(93.2%) | 14(100%) | 29(90.6%) | .236 | 43(93.4%) |
CIP | 2(12.5%) | 3(6.9%) | .498 | 5(8.7%) | 0 | 1(3.1%) | .504 | 1(2.1%) |
GM | 1(6.2%) | 4(9.3%) | .708 | 5(8.7%) | 0 | 0 | – | 0 |
SXT | 7(43.7%) | 10(23.2%) | .122 | 17(28.8%) | 1(7.1%) | 2(6.2%) | .910 | 3(6.5%) |
E | 8(50%) | 16(37.2%) | .374 | 24(40.6%) | 5(35.7%) | 13(40.6%) | .754 | 18(39.1%) |
CD | 11(68.7%) | 28(65.5%) | .793 | 37(62.7%) | 2(14.2%) | 9(28.1%) | .311 | 11(23.9%) |
RA | 6(37.5%) | 15(34.8%) | .852 | 21(35.5%) | 1(7.1%) | 4(12.5%) | .591 | 5(10.8%) |